Skip to main content
OpenTrials

Clinical trial condition

Scleroderma, Diffuse

Explore clinical trials studying Scleroderma, Diffuse. Study availability and eligibility vary by location and protocol.

220 public trials 50 recruiting studies
Refine in advanced search Browse all conditions

Scleroderma, Diffuse trial results

Recruiting

A Clinical Study to Evaluate Ianalumab in Participants With Diffuse Cutaneous Systemic Sclerosis

NCT06470048

Conditions
Connective Tissue Diseases, Diffuse Cutaneous Systemic Sclerosis, Scleroderma, Diffuse, +3 more
Locations
  • Arizona Arthritis and Rheumatology Research PLLC Mesa, Arizona, United States
  • UCLA Los Angeles, California, United States
  • Hoag Hospital Newport Beach, California, United States
  • Clinical Res Of W Florida Clearwater, Florida, United States
View all 128 locations
View Trial Details
Recruiting

Platform Clinical Study for Conquering Scleroderma

NCT06195072

Conditions
Connective Tissue Diseases, Interstitial Lung Disease Due to Systemic Disease, Lung Diseases, +7 more
Locations
  • University of Alabama - Division of Pulmonary and Critical Care Medicine Birmingham, Alabama, United States
  • Keck School of Medicine at USC Medical Center Los Angeles, California, United States
  • Cedars-Sinai Medical Center Los Angeles, California, United States
  • University of California, Los Angeles (UCLA) Ronald Reagan Medical Center Los Angeles, California, United States
View all 34 locations
View Trial Details
Recruiting

RESET-SSc: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201, a CD19-CAR T Cell Therapy, in Subjects With Systemic Sclerosis

NCT06328777

Conditions
Autoimmune Diseases, Connective Tissue Diseases, Immune System Diseases, +10 more
Locations
  • Yale University New Haven, Connecticut, United States
  • Mayo Clinic Florida Jacksonville, Florida, United States
  • Northwestern Memorial Hospital Chicago, Illinois, United States
  • The University of Chicago Medical Center Chicago, Illinois, United States
View Trial Details
Recruiting

A Safety and Efficacy Study Evaluating CTX112 in Adult Subjects With Refractory Autoimmune Disease

NCT06925542

Conditions
Autoimmune Diseases, Connective Tissue Diseases, Diffuse Cutaneous Systemic Sclerosis, +23 more
Locations
  • Stanford University Medical Center Redwood City, California, United States
  • Northwestern Medicine, Robert H. Lurie Comprehensive Cancer Center Chicago, Illinois, United States
  • University of Iowa Iowa City, Iowa, United States
  • Manning Family Children's Hospital of New Orleans New Orleans, Louisiana, United States
View all 14 locations
View Trial Details
Recruiting

A Phase 1/2 Study of NKX019 in Subjects With Immune-Mediated Diseases (Ntrust-2)

NCT06733935

Conditions
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, Antineutrophil Cytoplasmic Antibody-associated Vasculitis, Arthritis, +23 more
Locations
  • Nkarta Investigational Site Orange, California, United States
  • Nkarta Investigational Site Gainesville, Florida, United States
  • Nkarta Investigational Site Miami, Florida, United States
  • Nkarta Investigational Site Plantation, Florida, United States
View all 18 locations
View Trial Details
Recruiting

EncompaSSc: Evaluation of MTX-474 in Participants With Diffuse Cutaneous Systemic Sclerosis (dcSSc)

NCT07287670

Conditions
Connective Tissue Diseases, Diffuse Cutaneous Systemic Sclerosis, Scleroderma, Diffuse, +3 more
Locations
  • EncompaSSc site in Phoenix, AZ Phoenix, Arizona, United States
  • EncompaSSc site in La Jolla, CA La Jolla, California, United States
  • EncompaSSc site in Loma Linda, CA Loma Linda, California, United States
  • University of California Los Angeles Scleroderma Center Los Angeles, California, United States
View all 58 locations
View Trial Details

Related conditions